17-alpha-hydroxyprogesterone has been researched along with Uterine Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HENRIKSEN, E; VARGA, A | 2 |
| Caldarola, B; D'Addato, F; Ferraris, G; Lanza, A; Proserpio, D; Raspollini, M; Re, A; Rocca, G; Vigezzi, P; Zardo, L | 1 |
| Bakhidze, EV; Bokhman, IaV; Khavinson, VKh; Morozov, VG | 1 |
4 other study(ies) available for 17-alpha-hydroxyprogesterone and Uterine Neoplasms
| Article | Year |
|---|---|
Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Adenocarcinoma, Papillary; Caproates; Female; Humans; Hydroxyprogesterones; Progesterone; Uterine Neoplasms | 1961 |
EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Antineoplastic Agents; Caproates; Carcinoma, Squamous Cell; Choriocarcinoma; Female; Humans; Hydroxyprogesterones; Mesenchymoma; Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Pregnancy; Sarcoma; Uterine Cervical Neoplasms; Uterine Neoplasms | 1964 |
Hormonal and surgical treatment of endometrial adenocarcinoma: actuarial survival.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Prognosis; Uterine Neoplasms | 1988 |
[Use of thymalin in the complex treatment of patients with cancer of the uterus].
Topics: 17-alpha-Hydroxyprogesterone; Adjuvants, Immunologic; Combined Modality Therapy; Estradiol; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen; Thymus Hormones; Uterine Neoplasms | 1985 |